化工社
首页MCP工作台Skills
首页工作台通知我的
llms.txt · MCP 指南隐私政策 · 服务条款 · 支持v1.8.3
  1. 首页
  2. /化合物

氯吡拉敏

Chloropyramine

HCID 25295
新建反应
打印

正在补全数据,稍后刷新页面可查看最新内容

基本信息概述名称与标识性质安全与法规化学与工业相关反应化合物笔记
子结构检索查找相似结构

基本信息

CAS
59-32-5
标准SMILES
CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1
InChIKey
ICKFFNBDFNZJSX-UHFFFAOYSA-N
分子式
C16H20ClN3
平均分子量
289.8 g/mol
单同位素质量
289.1345753

概述

N'-[(4-chlorophenyl)methyl]-N,N-dimethyl-N'-(2-pyridinyl)ethane-1,2-diamine is an aminopyridine.

名称与标识

首选名称
Chloropyramine
IUPAC
N'-[(4-chlorophenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine
中文名
氯吡拉敏
英文名
Chloropyramine
分子式
C16H20ClN3
分子量
289.8

名称与别名

ChloropyramineHalopyramine59-32-5ChlorpyramineChlorneoanterganAnaphyllineAvapenaAllergan SChloroneoanterganCloropiraminaChloropyraminum2K3L8O9SOV
展开更多名称
氯吡胺氯吡拉敏化合物 CHLOROPYRAMINE2-[(4-氯苄基)[2-(二甲基氨基)乙基]氨基]吡啶AllerganSynpenSynopensynopenrallergansSuprastinSynopen R
NSC-241038Chloropyramine [INN:BAN:DCF]2-((p-Chlorobenzyl)(2-dimethylaminoethyl)amino)pyridineDTXSID50207729NSC241038Chloropyramine (INN:BAN:DCF)N-[(4-chlorophenyl)methyl]-N-[2-(dimethylamino)ethyl]pyridin-2-amineN-((4-chlorophenyl)methyl)-N-(2-(dimethylamino)ethyl)pyridin-2-amine

数据库标识

CAS
59-32-5
PubChem CID
25295
DTXSID
DTXSID50207729
ChEMBL
CHEMBL1194287、CHEMBL550011
ChEBI
CHEBI:94767
UNII
2K3L8O9SOV
EC Number
200-421-1
Nikkaji
J4.599C

性质

结构计算性质补全中

XLogP
3.9
极性表面积
19.4 Ų
氢键供体
0
氢键受体
3
可旋转键
6
重原子
20
形式电荷
0
复杂度
264

实验与物化性质

DrugsPharmaceuticals -> Listed in ZINC15
SolubilityInsoluble
Human DrugsPharmaceuticals
Melting Point · 2 条

< 25 °C

60 °C

Physical DescriptionSolid
Collision Cross Section166 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学性质

熔点
25 °C · 25°C
沸点
0.2 · bp0.2 154-155°
密度
1.1031 · 1.1031 (rough estimate)
折射率
1.601 · 1.6010 (estimate)
酸度系数(pKa)
9 · 9.00±0.28(Predicted)
NIST化学物质信息
Chloropyramine(59-32-5)

安全与法规

安全信息仅供参考,不能替代供应商安全技术说明书(SDS)、适用法规与专业评估。

GHS分类

GHS Classification · 4 条

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P233, P260, P261, P264, P264+P265, P270, P271, P280, P284, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P342+P316, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危害信息

Regulatory InformationREACH registered substance: Chloropyramine (EC: 200-421-1)
Hazard Classes and CategoriesAcute Tox. 4 (100%)

化学与工业

药理信息

ATC Code · 4 条

R - Respiratory system

D - Dermatologicals

QD - Dermatologicals

QR - Respiratory system

Pharmacodynamics · 1 条

Chlorpyramine is a competitive reversible H1 receptor antagonist. This inhibits vasodilation, increases in vascular permeability, and tissue edema associated with histamine release. In addition, chloropyramine has some anticholinergic properties. These effects, along with its ability to pass through the blood-brain barrier lead to side effects such as drowsiness, weakness, vertigo, fatigue, dryness in the mouth, constipation, and rarely - visual disturbances and increase of intraocular pressure.

Mechanism of ActionChloropyramine binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.
MeSH Pharmacological Classification · 1 条

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

Cellular LocationsMembrane
Metabolite PathwaysChloropyramine H1-Antihistamine Action

用途与制造

Use ClassificationPharmaceuticals

应用领域

相关反应

0 条
新建反应记录
还没有相关反应

化合物笔记

本页导航基本信息概述名称与标识性质安全与法规化学与工业相关反应化合物笔记

概述氯吡拉敏 是竞争性可逆 H1 受体拮抗剂。Chloropyramine 在乳腺癌中也具有抗肿瘤活性。Chloropyramine 可用于过敏性疾病的研究,如结膜炎和支气管哮喘。

上下游产品信息

上游原料

N1-(4-氯苄基)-N2,N2-二甲基乙烷-1,2-二胺N,N-二甲基-N'-(吡啶-2-基)乙烷-1,2-二胺(4-CHLORO-BENZYL)-PYRIDIN-2-YL-AMINE DIHYDROCHLORIDE2-溴吡啶2-氨基吡啶